Indian Journal of Health Sciences and Care

  • Year: 2015
  • Volume: 2
  • Issue: 2

Systemic Lupus Erythematosus Unmasked By Anti-Tubercular Treatment: A Rare Presentation

  • Author:
  • Jyoti Arora1, Pankaj Mehta2, Amit Kumar2, Vandita Sharma2, Rakhee Yadav3,
  • Total Page Count: 5
  • Page Number: 156 to 160

1Assistant Professor, Department of Physiology, Faculty of Medicine & Health Sciences, SGT University, Gurgaon, India

2Consultant, Department of Paediatrics, Sheetla Hospital, Gurgaon, India

3Assistant Professor, Department of Biochemistry, Faculty of Medicine & Health Sciences, SGT University, Gurgaon, India

Abstract

Systemic lupus erythematosus (SLE), is a systemic autoimmune disease in which the body's immune system mistakenly attacks its own healthy tissue. SLE is characterized by the presence of antibodies most commonly against a person's own proteins particularly against proteins in the cell nucleus; anti-nuclear antibodies, which are found in nearly all cases. These antibodies lead to inflammation. Although the underlying cause of autoimmune diseases is unknown, most believe that lupus results from both genetic and environmental stimuli. Today, over 90% survive for more than ten years, and many live relatively asymptomatically, 80–90% can expect to live a normal lifespan.

Keywords

SLE, ATT, Anti-nuclear antibodies, Tuberculosis